Kamagra Thailand - Buy kamagra Online

Allegra Members


Allegra Members Allegra Members

Methocarbamol 750 Mg What Is It


Methocarbamol 750 Mg What Is It Methocarbamol 750 Mg What Is It

Ciprofloxacina Hidrocortisona Gotas Oticas


Ciprofloxacina Hidrocortisona Gotas Oticas Ciprofloxacina Hidrocortisona Gotas Oticas

Allegra Cadence


Allegra Cadence Allegra Cadence

Amoxicillin Drug Card Nursing


Amoxicillin Drug Card Nursing Amoxicillin Drug Card Nursing


kamagra in your system
where to buy cheap kamagra
kamagra avant ou apres manger
kamagra forum romania
kamagra jelly how long to work
kamagra tablets bg
oralyely kamagra net
super kamagra safe sites uk
kamagra jelly hoe innemen
kamagra suppliers perth
kamagra jel kutuda ka
kamagra oral jelly cherry flavour
potenzmittel kamagra gel
kamagra rechnung
kamagra 247 reviews uk
kamagra now review
kamagra closed down
kamagra oral jelly f
kamagra tablets.co.uk
kamagrafast brighton
cheap kamagra kuala lumpur
site achat kamagra
frauen und kamagra
kamagra oral jelly uk collection
kamagra weight loss
kamagra finastride
is it possible to buy kamagra otc in australia
avis site kamagra
kamagra oral jelly in malaysia
kamagra in hyderabad india
kamagra jelly jhb
price different with kamagra et kamagra gold
alternative kamagranow
kamagra vo makedonija
kamagra nieuwsbrief

CoMentis, Inc. is focused on the research and development of small molecule drugs to treat CNS disorders. The company, with headquarters in South San Francisco, was founded based on the groundbreaking discoveries on structure, function, and inhibition of the beta-secretase enzyme by Jordan Tang, Ph.D., J.G. Puterbaugh Chair in Biomedical Research at the Oklahoma Medical Research Foundation and Arun K. Ghosh, Ph.D., Ian P. Rothwell Distinguished Professor - Organic Chemistry/Medicinal Chemistry at Purdue University.

CoMentis is developing an orally administered disease-modifying treatment for Alzheimer's disease that inhibits the beta-secretase enzyme to reduce the formation of beta amyloid peptides, thereby preventing deleterious effects of accumulated amyloid peptides and downstream pathologies.  Beta amyloid peptides aggregate to form soluble polymers and insoluble plaques in the brain, implicated in the development of Alzheimer's disease.  Inhibition of beta-secretase reduces amyloid beta production and could block the progression of Alzheimer's disease.

CoMentis is currently pursuing the development of beta-secretase inhibitor drugs in partnership with Astellas Pharma, Inc., under terms of an exclusive worldwide collaboration agreement initiated in 2008.